D E Moulin

Summary

Affiliation: University of Western Ontario
Country: Canada

Publications

  1. ncbi Systemic drug treatment for chronic musculoskeletal pain
    D E Moulin
    Department of Clinical Neurological Sciences Oncology, University of Western Ontario, London, Canada
    Clin J Pain 17:S86-93. 2001
  2. ncbi Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society
    D E Moulin
    University of Western Ontario, London, Ontario, Canada
    Pain Res Manag 12:13-21. 2007
  3. ncbi Does acute pain associated with herpes zoster respond to treatment with gabapentin?
    Dwight Moulin
    Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada
    Nat Clin Pract Neurol 2:298-9. 2006
  4. ncbi Treatment of neuropathic pain with venlafaxine
    J E Sumpton
    Pharmacy Department, London Health Sciences Centre, Ontario, Canada
    Ann Pharmacother 35:557-9. 2001
  5. ncbi The multidimensional pain inventory profiles in patients with chronic cancer-related pain: an examination of generalizability
    C Zaza
    Department of Oncology, University of Western Ontario, Canada
    Pain 87:75-82. 2000
  6. ncbi Role of health care professionals in multidisciplinary pain treatment facilities in Canada
    Philip Peng
    Wasser Pain Management Centre, Mount Sinai Hospital, Department of Anesthesiology, University of Toronto, Toronto, Ontario, Canada
    Pain Res Manag 13:484-8. 2008
  7. ncbi Methadone in the management of intractable neuropathic noncancer pain
    D E Moulin
    Departments of Clinical Neurological Sciences, Faculty of Medicine, University of Western Ontario, London, Ontario, Canada
    Can J Neurol Sci 32:340-3. 2005
  8. ncbi Evaluation of dosing guidelines for use of controlled-release codeine in chronic noncancer pain
    Alan Russell
    William Osler Health Centre, Brampton, Ontario, Canada
    Pain Res Manag 8:143-8. 2003
  9. ncbi Use of methadone for neuropathic pain
    Dwight Moulin
    Pain Res Manag 8:131-2. 2003
  10. ncbi A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008--a long-acting, parenteral opioid analgesic--in the treatment of postherpetic neuralgia
    Mark S Wallace
    Department of Anesthesiology, University of California San Diego, USA
    J Opioid Manag 2:167-73. 2006

Collaborators

Detail Information

Publications13

  1. ncbi Systemic drug treatment for chronic musculoskeletal pain
    D E Moulin
    Department of Clinical Neurological Sciences Oncology, University of Western Ontario, London, Canada
    Clin J Pain 17:S86-93. 2001
    ..The purpose of this review was to determine how effective different classes of analgesic agents are in the management of chronic pain...
  2. ncbi Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society
    D E Moulin
    University of Western Ontario, London, Ontario, Canada
    Pain Res Manag 12:13-21. 2007
    ..Further studies are required to examine head-to-head comparisons among analgesics, combinations of analgesics, long-term outcomes, and treatment of pediatric and central NeP...
  3. ncbi Does acute pain associated with herpes zoster respond to treatment with gabapentin?
    Dwight Moulin
    Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada
    Nat Clin Pract Neurol 2:298-9. 2006
  4. ncbi Treatment of neuropathic pain with venlafaxine
    J E Sumpton
    Pharmacy Department, London Health Sciences Centre, Ontario, Canada
    Ann Pharmacother 35:557-9. 2001
    ..To report a case of successful treatment of neuropathic pain with venlafaxine...
  5. ncbi The multidimensional pain inventory profiles in patients with chronic cancer-related pain: an examination of generalizability
    C Zaza
    Department of Oncology, University of Western Ontario, Canada
    Pain 87:75-82. 2000
    ..Whereas the MPI-based profiles are consistent across non-malignant pain problems, it appears that the nature of cancer may affect the MPI-based profile classification system more than non-malignant pain problems do...
  6. ncbi Role of health care professionals in multidisciplinary pain treatment facilities in Canada
    Philip Peng
    Wasser Pain Management Centre, Mount Sinai Hospital, Department of Anesthesiology, University of Toronto, Toronto, Ontario, Canada
    Pain Res Manag 13:484-8. 2008
    ..To examine the role of health care professionals in multidisciplinary pain treatment facilities (MPTF) for the treatment of chronic pain across Canada...
  7. ncbi Methadone in the management of intractable neuropathic noncancer pain
    D E Moulin
    Departments of Clinical Neurological Sciences, Faculty of Medicine, University of Western Ontario, London, Ontario, Canada
    Can J Neurol Sci 32:340-3. 2005
    ..This observation needs to be tested in randomized, controlled trials...
  8. ncbi Evaluation of dosing guidelines for use of controlled-release codeine in chronic noncancer pain
    Alan Russell
    William Osler Health Centre, Brampton, Ontario, Canada
    Pain Res Manag 8:143-8. 2003
    ..CONCLUSION: The results confirm the safety, efficacy and patient acceptability of the initial conversion and maintenance dosing recommendations for CR codeine from a combination opioid/nonopioid analgesic...
  9. ncbi Use of methadone for neuropathic pain
    Dwight Moulin
    Pain Res Manag 8:131-2. 2003
  10. ncbi A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008--a long-acting, parenteral opioid analgesic--in the treatment of postherpetic neuralgia
    Mark S Wallace
    Department of Anesthesiology, University of California San Diego, USA
    J Opioid Manag 2:167-73. 2006
    ..However, the effect only lasted through eight hours postdose and diminished by 24 hours. This study provides evidence of a peripheral action of dynorphin, since CJC-1008 does not cross the blood-brain barrier...
  11. ncbi Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy
    C Peter N Watson
    University of Toronto, Toronto, ON, Canada
    Pain 105:71-8. 2003
    ..Painful neuropathy is one of the most common long-term complications of diabetes mellitus and often proves difficult to relieve...
  12. ncbi An open-label, multi-dose efficacy and safety study of intramuscular tetrodotoxin in patients with severe cancer-related pain
    Neil A Hagen
    Tom Baker Cancer Centre, Calgary, Alberta, Canada
    J Pain Symptom Manage 34:171-82. 2007
    ..It effectively relieved severe, treatment-resistant cancer pain in the majority of patients and often for prolonged periods after treatment. It may have a novel mechanism of analgesic effect. Further study is warranted...
  13. ncbi Use of opioid analgesics for the treatment of chronic noncancer pain--a consensus statement and guidelines from the Canadian Pain Society, 2002
    Roman D Jovey
    Alcohol and Drug Treatment Program, Credit Valley Hospital, Suite G-01, 2300 Eglinton Avenue West, Mississauga, Ontario L5M 2V8, Canada
    Pain Res Manag 8:3A-28A. 2003